Horizon Therapeutics plc launches #RAREis Global Advocate Grant program to…

05/06/2022 – 11:44 Therapeutic Horizon Dublin (ots) Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of #RAREice Announcement of the Global Advocate grant. This is a program designed to support the rare disease community by providing financial assistance to US and global patient advocacy groups working to advance, educate, and meet community needs. With … Read more